PMID- 26923065 OWN - NLM STAT- MEDLINE DCOM- 20180104 LR - 20180104 IS - 1090-2139 (Electronic) IS - 0889-1591 (Linking) VI - 56 DP - 2016 Aug TI - Alteration of transcriptional networks in the entorhinal cortex after maternal immune activation and adolescent cannabinoid exposure. PG - 187-96 LID - S0889-1591(16)30041-1 [pii] LID - 10.1016/j.bbi.2016.02.021 [doi] AB - Maternal immune activation (MIA) and adolescent cannabinoid exposure (ACE) have both been identified as major environmental risk factors for schizophrenia. We examined the effects of these two risk factors alone, and in combination, on gene expression during late adolescence. Pregnant rats were exposed to the viral infection mimic polyriboinosinic-polyribocytidylic acid (poly I:C) on gestational day (GD) 15. Adolescent offspring received daily injections of the cannabinoid HU210 for 14days starting on postnatal day (PND) 35. Gene expression was examined in the left entorhinal cortex (EC) using mRNA microarrays. We found prenatal treatment with poly I:C alone, or HU210 alone, produced relatively minor changes in gene expression. However, following combined treatments, offspring displayed significant changes in transcription. This dramatic and persistent alteration of transcriptional networks enriched with genes involved in neurotransmission, cellular signalling and schizophrenia, was associated with a corresponding perturbation in the expression of small non-coding microRNA (miRNA). These results suggest that a combination of environmental exposures during development leads to significant genomic remodeling that disrupts maturation of the EC and its associated circuitry with important implications as the potential antecedents of memory and learning deficits in schizophrenia and other neuropsychiatric disorders. CI - Copyright (c) 2016 Elsevier Inc. All rights reserved. FAU - Hollins, Sharon L AU - Hollins SL AD - School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Schizophrenia Research Institute, Sydney, NSW, Australia; Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia. FAU - Zavitsanou, Katerina AU - Zavitsanou K AD - School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia. FAU - Walker, Frederick Rohan AU - Walker FR AD - School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia. FAU - Cairns, Murray J AU - Cairns MJ AD - School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Schizophrenia Research Institute, Sydney, NSW, Australia; Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia. Electronic address: murray.cairns@newcastle.edu.au. LA - eng PT - Journal Article DEP - 20160226 PL - Netherlands TA - Brain Behav Immun JT - Brain, behavior, and immunity JID - 8800478 RN - 0 (Cannabinoid Receptor Agonists) RN - 7J8897W37S (Dronabinol) RN - O84C90HH2L (Poly I-C) RN - R6VT8U5372 (HU 211) SB - IM MH - Age Factors MH - Animals MH - Cannabinoid Receptor Agonists/administration & dosage/*pharmacology MH - Disease Models, Animal MH - Dronabinol/administration & dosage/analogs & derivatives/pharmacology MH - *Entorhinal Cortex/drug effects/immunology/metabolism MH - Female MH - *Gene Expression/drug effects/genetics/immunology MH - *Gene Regulatory Networks/drug effects/genetics/immunology MH - *Poly I-C/administration & dosage MH - Pregnancy MH - *Prenatal Exposure Delayed Effects/immunology MH - Rats MH - Rats, Wistar MH - *Virus Diseases/immunology OTO - NOTNLM OT - Brain OT - Cannabinoid OT - Entorhinal cortex OT - Gene expression OT - Maternal infection OT - Schizophrenia EDAT- 2016/03/01 06:00 MHDA- 2018/01/05 06:00 CRDT- 2016/03/01 06:00 PHST- 2015/01/28 00:00 [received] PHST- 2016/02/16 00:00 [revised] PHST- 2016/02/24 00:00 [accepted] PHST- 2016/03/01 06:00 [entrez] PHST- 2016/03/01 06:00 [pubmed] PHST- 2018/01/05 06:00 [medline] AID - S0889-1591(16)30041-1 [pii] AID - 10.1016/j.bbi.2016.02.021 [doi] PST - ppublish SO - Brain Behav Immun. 2016 Aug;56:187-96. doi: 10.1016/j.bbi.2016.02.021. Epub 2016 Feb 26.